| Literature DB >> 31212610 |
Setor K Kunutsor1,2, Vikki Wylde3,4, Michael R Whitehouse5,6, Andrew D Beswick7, Erik Lenguerrand8, Ashley W Blom9,10.
Abstract
The type of fixation used in primary total knee replacement (TKR) may influence the risk of prosthetic joint infection (PJI). We conducted a systematic review and meta-analysis to assess published evidence linking type of fixation (cemented, uncemented, or hybrid) with the risk of PJI following primary TKR. Randomised controlled trials (RCTs) and observational cohort studies comparing fixation methods and reporting PJI incidence following primary TKR were identified in MEDLINE, Embase, Web of Science, and Cochrane Library up until November 2018. Summary measures were relative risks (RR) with 95% confidence intervals (CIs). We identified 32 eligible articles (24 observational studies and 8 RCTs) involving 1,161,292 TKRs. In pooled analysis of observational studies, uncemented fixation was associated with a decreased overall PJI risk when compared with cemented fixation at 0.76 (0.64-0.89). Comparing antibiotic-loaded cemented fixation with plain cement, there was no significant difference in overall PJI risk at 0.95 (0.69-1.31), but PJI risk was increased in the first 6-month postoperative period to 1.65 (1.12-2.43). Limited data from RCTs showed no differences in PJI risk among the fixation types. Observational evidence suggests uncemented fixation may be associated with lower PJI risk in primary TKR when compared with cemented fixation. In the early postoperative period, antibiotic-loaded cemented fixation may be associated with increased PJI risk when compared with plain cement. This may either reflect appropriate selection of higher risk patients for the development of PJI to cemented and antibiotic-loaded cement or may reflect a lower PJI risk in uncemented TKR due to factors such as shorter operative time.Entities:
Keywords: antibiotic-loaded cement; cemented; fixation; hybrid; meta-analysis; prosthetic joint infection; total knee replacement; uncemented
Year: 2019 PMID: 31212610 PMCID: PMC6616920 DOI: 10.3390/jcm8060828
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1PRISMA flow diagram; Note: RCT, randomised controlled trial.
Characteristics of studies included in review.
| Author, Year of Publication | Year of Study | Country | Indication for Total Hip Replacement | Average Age (Years) | Design, Source of Data | Fixation Types Compared | Mean/Median Follow-Up Duration, Years | No. of Participants/Knees | Infection Outcome Reported (Definition) | No. of PJIs | Study Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Wilson, 1990 | 1973–1987 | U.S. | NR | NR | Observational cohort, Hospital | Uncemented, cemented, hybrid | Up to 6.0 years | 4171 | Deep infection (Purulent material obtained from joint and positive bacterial culture) | 67 | 4 |
| Duffy, 1998 | 1985–1987 | U.S. | Uncemented (OA 76.4%; RA 16.4%; PTA 5.5%; ankylosing spondylitis 1.8%); Cemented (OA 82.4%; RA 11.8%; ancient sepsis 3.9%; osteonecrosis 2.0%) | 59.6 | Retrospective cohort | Uncemented, cemented | 10.0 | 106 | Revision for infection (NR) | 1 | 4 |
| McCaskie, 1998 | 1987–1990 | U.K. | Cemented (OA 84%); Uncemented (OA 86%) | 68.8–70.2 | RCT, Hospital | Uncemented, cemented | 5.0 | 113 | Infection (NR) | 1 | NA |
| Pecina, 2000 | 1985–1991 | Croatia | OA 68.3%; RA 31.7% | 61.0 | Observational cohort | Uncemented, cemented, hybrid | 7.3 | 142 | Revision for infection (NR) | 5 | 5 |
| Eveillard, 2003 | 1995–1999 | France | NR | NR | Observational cohort, Hospital | Antibiotic loaded cement, plain cement | At least 1 year | 167 | Infection (Isolation of organisms from tissue sample; confirmed by surgeon) | 9 | 5 |
| Baker, 2007 | 1987–1997 | U.K. | OA 91.4%; RA 7.6%; other 1.0% | 70.5 | RCT | Uncemented, cemented | 8.7–8.9 | 396 | Revision for infection (NR) | 11 | NA |
| Beaupre, 2007 | 1996–2000 | Canada | Non-inflammatory arthritis 100% | 63.4 | RCT | Uncemented, hybrid | 5.0 | 81 | Infection (NR) | 6 | NA |
| Jamsen, 2009 | 1997–2004 | Finland | Primary OA 87.9%; secondary OA 2.7%; RA 7.6%; other arthritis 1.0%; other 0.8% | 71.0 | Retrospective cohort, FAR and FHDR | Uncemented, cemented, hybrid | 3.1 | 40,135 | Revision for infection (NR) | 387 | 7 |
| Dowsey, 2009 | 1998–2005 | Australia | OA 91.8%; RA 7.8%; osteonecrosis 0.2%; trauma 0.2% | 72.0 | Retrospective cohort, Institutional database | Antibiotic loaded cement, plain cement | 1.0 | 1214 | PJI (CDC criteria) | 18 | 6 |
| Ghandi, 2009 | 1998–2006 | Canada | Primary or secondary OA; RA | 66.1 | Retrospective cohort, Hospital | Antibiotic loaded cement, plain cement | 1.0 | 1625 | Deep infection (CDC criteria) | 43 | 5 |
| Namba, 2009 | 2003–2007 | U.S. | OA 92.4%; other 7.6% | 68.0 | Retrospective cohort, community-based registry | Antibiotic loaded cement, plain cement | NR | 22,889 | Deep infection (CDC criteria) | 182 | 8 |
| Demey, 2011 | 2004–2005 | France | OA (96.9%); chondrocalcinosis (3.1%) | 72.3 | RCT | Hybrid, cemented | 2.7–2.8 | 130 | Deep infection (NR) | 1 | NA |
| Namba, 2013 | 2001–2009 | U.S. | OA 96.8%; PTA 1.2%; RA 2.2%; osteonecrosis 0.4%; other 0.9% | 67.4 | Retrospective cohort, Registry | Antibiotic loaded cement, plain cement | NR | 56,216 | Deep SSI (CDC criteria) | 404 | 8 |
| Lass, 2013 | 2003–2007 | Austria | Idiopathic arthritis 88.3%; PTA 5.0%; RA 3.3%; avascular necrosis 0.8% | 66.9 | Observational cohort | Uncemented, hybrid | 5.0 | 120 | Revision for infection (NR) | 1 | 5 |
| Pelt, 2013 | NR | U.S. | Hybrid (OA 95%; RA 2%; PTA 3%; other 0%); Cemented (OA 90%; RA 7%; PTA 2%; other 1%) | 59.3–65.9 | Observational cohort | Hybrid, cemented | 3.2–4.1 | 304 | Revision for sepsis (NR) | 5 | 5 |
| Hinarejos, 2013 | 2005–2010 | Spain | NR | 75.9 | RCT | Antibiotic loaded cement, plain cement | 3.2 | 2948 | Deep and superficial infection (CDC criteria) | 85 | NA |
| Qadir, 2014 | 2000–2010 | U.S. | NR | 68.1 | Retrospective cohort, Institutional registry | Antibiotic loaded cement, plain cement | 1.0 | 2511 | Infection (CDC criteria) | 17 | 6 |
| Gutowski, 2014 | 2000–2002; 2004–2007 | U.S. | NR | 65.8 | Retrospective cohort, Hospital | Antibiotic loaded cement, plain cement | Over a 3.0-year period | 7878 | PJI (MSIS criteria) | 63 | 5 |
| Bohm, 2014 | 2003–2008 | Canada | OA 100% | 70.0 | Retrospective cohort, CIHI and CJRR | Antibiotic loaded cement, plain cement | 2.0 | 36,681 | Revision for infection (NR) | 36 | 6 |
| Choy, 2014 | 2002–2004 | Korea | OA 100% | 67.8 | RCT | Uncemented, hybrid | 9.5 | 168 | SSI (NR) | 2 | NA |
| Lizaur-Utrilla, 2014 | 1999–2007 | Spain | OA (92.5%); PTA (7.5%) | 51.7 | RCT | Uncemented, hybrid | 7.1 | 93 | Deep wound infection (NR) | 1 | NA |
| Petursson, 2015 | 1999–2012 | Norway | Primary OA 90%; other 10% | 69.0 | Observational cohort, NAR | Hybrid, cemented | 11.0 | 24,680 | Revision for infection (NR) | 217 | 7 |
| Wang, 2015 | 2003–2012 | China | OA 87.8%; other 12.2% | 64.8 | Retrospective cohort, Hospital | Antibiotic loaded cement, plain cement | 1.0 | 2293 | Deep infection (CDC criteria) | 10 | 6 |
| Fricka, 2015 | 2010–2012 | U.S. | NR | 58.6–60.2 | RCT | Uncemented, cemented | 2.0 | 100 | PJI (NR) | 1 | NA |
| Tayton, 2016 | 1999–2012 | New Zealand | OA 95%; AVN 0.3%; Trauma 1.2%; RA 3.4%; other 0.2% | <55 to >75 * | Prospective cohort, New Zealand Joint Registry | Antibiotic-loaded cement, plain cement | 1.0 | 64,566 | Revision for infection (NR) | 179 | 7 |
| Wu, 2016 | 2009–2013 | Taiwan | OA, RA, PTA | 69.7 | Retrospective cohort | Antibiotic-loaded cement, plain cement | 1.0–5.0 | 3152 | SSI (CDC criteria) | 48 | 6 |
| Prudhon, 2017 | 2003–2006 | France | OA 88.5%; post-traumatic OA 3.0%; RA 4.5%; patellofemoral OA 4.0% | 73.0 | Observational cohort | Uncemented, cemented | 12.1–13.7 | 200 | Infection (NR) | 1 | 5 |
| Sanz-Ruiz, 2017 | 2009–2012 | Spain | NR | 76.1–76.4 | Prospective cohort | Antibiotic-loaded cement, plain cement | 2.0 (minimum) | 1250 | Infection (MSIS criteria) | 30 | 4 |
| Vertullo, 2018 | 1999–2015 | Australia | OA 100% | 69.0 | Observational cohort, Registry | Hybrid, cemented | 13.0 | 39,623 | Revision for infection (NR) | 215 | 7 |
| Gwam, 2018 | 2015 | U.S. | OA 100% | 65.8 | Retrospective cohort, NIS database | Uncemented, cemented | NR | 167,930 | SSI (NR) | NR | 5 |
| Lenguerrand, 2018 | 2003–2013 | U.K. | OA (97.3%); other (2.7%) | 69.0 | Prospective cohort, Registry | Uncemented, cemented | 4.6 | 679,010 | Revision for infection (NR) | 3227 | 7 |
| Miller, 2018 | 2013–2014 | U.S. | NR | 64.4 | Institutional database | Uncemented, cemented | 2.4–5.3 | 400 | Infection (NR) | 1 | 5 |
Note: *, age range of participants; CDC, Centres for Disease Control Prevention; CIHI, Canadian Institute for Health Information; CJRR, Canadian Joint Replacement Registry; FAR, Finnish Arthroplasty Register; FHDR, Finnish Hospital Discharge Register; MSIS, Musculoskeletal Infection Society; NA, not applicable; NAR, Norwegian Arthroplasty Register; NIS, National Inpatient Sample; NR, not reported; OA, osteoarthritis; PJI, prosthetic joint infection; PTA, post-traumatic arthritis; RA, rheumatoid arthritis; RCT, randomised controlled trial; SSI, surgical site infection.
Figure 2Fixation types in primary total knee replacement and risk of prosthetic joint infection in observational studies and randomised controlled trials. Note: CI, confidence interval (bars); PJI, prosthetic joint infection; RR, relative risk.
Figure 3Comparison of all antibiotic-loaded cemented fixation with plain cemented fixation in primary total knee replacement and the risk of prosthetic joint infection in observational studies, grouped according to several study characteristics. Note: CI, confidence interval (bars); PJI, prosthetic joint infection; RR, relative risk; *, p-value for meta-regression.